With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this […]

Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA […]

Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd […]